Bayland Capital is a leading investment firm with a focus on innovative life science companies globally.
Bayland Capital is a leading investment firm with a focus on innovative life science companies globally.
| 
                        Date
                        Company Name
                     | Round | Money Raised | Industry | Lead Investor | 
|---|---|---|---|---|
| 
                      Jan 12, 2023
                      
                            LePure Biotech | Series C | — | Biopharma | — | 
| 
                      Aug 26, 2022
                      
                           | Series A | $10M | Medical | — | 
| 
                      Nov 5, 2021
                      
                            Wuxi Biortus Biosciences | Series B | ¥200M | Biotechnology | Yes | 
| 
                      Nov 13, 2020
                      
                            Wuxi Biortus Biosciences | Series A | $15M | Biotechnology | Yes |